We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
751
Accendra Health
ACH
$240M
| $4.86M | 0.01% |
1,186,219
+436,116
| +58% | +$2.76M |
|
752
Huntington Ingalls Industries
HII
$11.3B
| $4.85M | 0.01% |
23,391
-2,828
| -11% | -$580K |
|
|
VRTV
753
DELISTED
VERITIV CORPORATION
VRTV
| $4.84M | 0.01% |
183,842
+20,273
| +12% | +$620K |
|
754
Cognizant
CTSH
$20.3B
| $4.84M | 0.01% |
66,743
+43,095
| +182% | +$3.02M |
|
755
Paychex
PAYX
$39.4B
| $4.8M | 0.01% |
59,805
+52,621
| +732% | +$3.88M |
|
756
Aecom
ACM
$8.69B
| $4.79M | 0.01% |
161,432
-11,992
| -7% | -$358K |
|
757
Emerson Electric
EMR
$81.2B
| $4.75M | 0.01% |
69,373
-195
| -0.3% | -$12.8K |
|
758
Moody's
MCO
$82.5B
| $4.71M | 0.01% |
26,020
+21,768
| +512% | +$3.58M |
|
759
American Express
AXP
$233B
| $4.7M | 0.01% |
42,983
-3,701
| -8% | -$389K |
|
760
Linde
LIN
$234B
| $4.69M | 0.01% |
26,674
+19,368
| +265% | +$3.22M |
|
761
Tenet Healthcare
THC
$17.1B
| $4.65M | 0.01% |
161,245
-45,193
| -22% | -$1.12M |
|
762
Baxter International
BAX
$11.2B
| $4.64M | 0.01% |
57,012
+39,452
| +225% | +$2.87M |
|
763
GameStop
GME
$9.58B
| $4.54M | 0.01% |
1,788,352
+346,456
| +24% | +$1.08M |
|
|
AXE
764
DELISTED
Anixter International Inc
AXE
| $4.53M | 0.01% |
80,802
+7,944
| +11% | +$464K |
|
765
Realty Income
O
$60.4B
| $4.42M | 0.01% |
61,990
+3,467
| +6% | +$230K |
|
766
Marriott International
MAR
$96.1B
| $4.4M | 0.01% |
35,162
+17,341
| +97% | +$2.04M |
|
767
Tower Semiconductor
TSEM
$29.4B
| $4.37M | 0.01% |
264,108
+25,412
| +11% | +$407K |
|
|
DF
768
DELISTED
Dean Foods Company
DF
| $4.37M | 0.01% |
1,442,997
+574,171
| +66% | +$2.31M |
|
769
Nutanix
NTNX
$14.2B
| $4.36M | 0.01% |
+115,563
| New | +$5.29M |
|
770
Cummins
CMI
$91.8B
| $4.33M | 0.01% |
27,401
+11,361
| +71% | +$1.7M |
|
771
Southern Company
SO
$109B
| $4.32M | 0.01% |
83,593
+34,917
| +72% | +$1.71M |
|
|
UMPQ
772
DELISTED
Umpqua Holdings Corp
UMPQ
| $4.32M | 0.01% |
261,794
+211,526
| +421% | +$3.72M |
|
773
T. Rowe Price
TROW
$24.6B
| $4.29M | 0.01% |
42,880
+34,829
| +433% | +$3.36M |
|
|
VSM
774
DELISTED
Versum Materials, Inc.
VSM
| $4.05M | 0.01% |
80,579
+66,743
| +482% | +$2.66M |
|
|
MGLN
775
DELISTED
Magellan Health Services, Inc.
MGLN
| $4M | 0.01% |
60,713
+928
| +2% | +$59.6K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.